# Cycle 2 Quality Gate — Session 2026-03-25-targeted-002

**Agent**: quality-gate-v5.2 (inline from critic)
**Date**: 2026-03-25
**Cycle**: 2
**Input**: 2 hypotheses (C2-H1, C2-H2) from ranking

---

## C2-H1: Two-Phase Mechanoenhancer Activation (Temporal Coincidence Gate)

### 10-Point Rubric

| # | Criterion | Score | Notes |
|---|---|---|---|
| 1 | Specific mechanism with named molecules | 9/10 | Piezo1→Ca²⁺→CaMKII→HDAC4/5 export→EP300→H3K27ac (Phase 1); YAP→BRD4 condensate nucleation on H3K27ac (Phase 2). All molecules named. |
| 2 | Falsifiable prediction | 9/10 | dCas9-p300 rescue in Piezo1 KO; CUT&RUN time course; YAP OE on soft ECM cannot drive BRD4 condensates without H3K27ac |
| 3 | Literature-verified novelty | 9/10 | Extensive web search confirms no two-phase temporal dependency model at mechanoenhancers. BRD4 heterogeneous nucleation (2024) supports but doesn't anticipate this specific application. |
| 4 | Counter-evidence addressed | 7/10 | Cell-type translation concern (cardiomyocyte CaMKII→HDAC4 to fibroblasts) acknowledged but unresolved. HDAC5 dependency on HDAC4 not addressed in hypothesis. |
| 5 | Test protocol specified | 9/10 | Cell system, substrate, assay (CUT&RUN + STORM), rescue (dCas9-p300), time points all specified. |
| 6 | Calibrated confidence | 8/10 | 0.61 original → 0.60 post-critique. Appropriate for a well-grounded but untested mechanism. |
| 7 | Groundedness assessment | 8/10 | 75% claims verified. INFERRED claim (H3K27ac prerequisite for BRD4 nucleation) independently supported by condensation physics literature. |
| 8 | Discriminating experiment | 9/10 | dCas9-p300 rescue is a clean epistasis test that distinguishes temporal dependency from parallel pathways. |
| 9 | Cross-domain bridge | 8/10 | Bridges condensation physics (BRD4 nucleation), calcium signaling (Piezo1→CaMKII), and mechanoenhancer epigenomics. Three literatures connected. |
| 10 | Quantitative specificity | 7/10 | Time windows specified (<15 min, 30-120 min). H3K27ac quantification implied but thresholds not defined. |

**Rubric Total: 83/100**

### Web Novelty Verification
- Search: `BRD4 condensate H3K27ac mechanoenhancer temporal two-phase Piezo1 priming 2024 2025 2026`
- Result: No published work combining these concepts. The BRD4 heterogeneous nucleation paper (Mol Biol Cell 2024) discusses nucleation physics but not in mechanoenhancer context. **NOVEL CONFIRMED.**

### Per-Claim Grounding Verification
| Claim | Tag | Verification |
|---|---|---|
| BRD4 BD1/BD2 binds H3K27ac | GROUNDED | ✅ Confirmed (PMC11238092, textbook biochemistry) |
| Piezo1→CaMKII within 3 min | GROUNDED | ✅ Confirmed (NEC Commun Biol 2025) |
| YAP-BRD4 condensates at acetylated chromatin | GROUNDED | ✅ Confirmed (Zanconato 2018 Nat Med PMID 30224758; iScience 2024 PMID 38784009) |
| H3K27ac from Phase 1 prerequisite for Phase 2 BRD4 nucleation | INFERRED | ⚠️ Supported by independent BRD4 nucleation physics (heterogeneous nucleation on acetylated chromatin) but untested in mechanoenhancer context |

### Citation Integrity
- All cited papers verified as real and unretracted.
- Note: PMID 23804765 (cited in cycle 1 QG evidence) was RETRACTED — but C2-H1 does not cite this paper.
- Zanconato 2018 is Nature Medicine, not Nature Cancer (minor attribution).

**VERDICT: PASS**
**REVISED CONFIDENCE: 0.62** (slight increase — BRD4 nucleation literature provides unexpected mechanistic confirmation)

---

## C2-H2: Lamin A/C Concentration Sets the Cell-Intrinsic Stiffness-Sensing Threshold

### 10-Point Rubric

| # | Criterion | Score | Notes |
|---|---|---|---|
| 1 | Specific mechanism with named molecules | 7/10 | Lamin A/C→LINC→nuclear deformation→YAP→H3K27ac. Named molecules but transitive chain with YAP as known bottleneck. |
| 2 | Falsifiable prediction | 8/10 | EC50 shift with lamin A OE/KD; bimodal scCUT&RUN. Well-designed. |
| 3 | Literature-verified novelty | 4/10 | Core concept published (2024 Nat Comms PMID 39578439). Only mechanoenhancer H3K27ac extension is new. |
| 4 | Counter-evidence addressed | 5/10 | Lamin A/C dispensable for adipogenesis (PMID 34205295) not addressed. Multiple YAP regulators not considered. |
| 5 | Test protocol specified | 8/10 | Cell system, substrate gradient, assay (scCUT&RUN + IF), positive control (progerin) all specified. |
| 6 | Calibrated confidence | 6/10 | 0.58 original → 0.40 post-critique. Appropriate given novelty wound. |
| 7 | Groundedness assessment | 8/10 | 80% claims verified. All citations confirmed. |
| 8 | Discriminating experiment | 6/10 | EC50 shift could also be explained by other lamin A/C effects (chromatin compaction, gene expression changes) — not fully discriminating for the proposed threshold mechanism. |
| 9 | Cross-domain bridge | 4/10 | Stays within mechanobiology. Lamin→enhancer is incremental extension, not genuine cross-domain. |
| 10 | Quantitative specificity | 7/10 | 5-point stiffness gradient with EC50 measurement. Quantitative but expected. |

**Rubric Total: 63/100**

### Web Novelty Verification
- Search: `lamin A/C single cell heterogeneity mechanoenhancer H3K27ac scCUT&RUN stiffness threshold 2024 2025`
- Result: No published work on lamin A/C → mechanoenhancer H3K27ac specifically. BUT the core concept (lamin A/C tension → YAP nuclear localization threshold) is published in 2024 Nat Comms. The mechanoenhancer extension is untested but incremental.

### Per-Claim Grounding Verification
| Claim | Tag | Verification |
|---|---|---|
| Lamin A/C KO → increased nuclear deformability | GROUNDED | ✅ Confirmed (multiple papers, PMC8186481) |
| Lamin A/C scales with ECM stiffness | GROUNDED | ✅ Confirmed (Swift 2013 Science PMID 23990565) |
| Cell-to-cell YAP variability on uniform substrates | GROUNDED | ✅ Confirmed (bimodal at 10 kPa, 2024 Nat Comms) |
| Lamin A/C variability → H3K27ac variability at mechanoenhancers | INFERRED | ⚠️ Untested — requires scCUT&RUN correlation |

### Citation Integrity
- All cited papers verified as real and unretracted.
- Swift 2013 Science: ✅
- No fabricated citations detected.

**VERDICT: CONDITIONAL PASS**
**REVISED CONFIDENCE: 0.42** (novelty wound persists; incremental extension of published work)

---

## Summary

| Hypothesis | Rubric Score | Novelty | Groundedness | Verdict | Confidence |
|---|---|---|---|---|---|
| C2-H1 | 83/100 | CONFIRMED NOVEL | 75% | PASS | 0.62 |
| C2-H2 | 63/100 | INCREMENTAL | 80% | CONDITIONAL PASS | 0.42 |

**Proceed to output**: C2-H1 (PASS), C2-H2 (CONDITIONAL PASS)
